PLETAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pletal, and when can generic versions of Pletal launch?
Pletal is a drug marketed by Otsuka and is included in one NDA.
The generic ingredient in PLETAL is cilostazol. There are twelve drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cilostazol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pletal
A generic version of PLETAL was approved as cilostazol by EPIC PHARMA LLC on November 23rd, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PLETAL?
- What are the global sales for PLETAL?
- What is Average Wholesale Price for PLETAL?
Summary for PLETAL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 128 |
Clinical Trials: | 20 |
Patent Applications: | 5,139 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PLETAL at DailyMed |
![PLETAL drug patent expirations Drug patent expirations by year for PLETAL](/p/graph/s/t/PLETAL-patent-expirations.png)
Recent Clinical Trials for PLETAL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Asan Medical Center | Phase 4 |
Kangbuk Samsung Hospital | Phase 4 |
University of Nottingham | Phase 2 |
US Patents and Regulatory Information for PLETAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Otsuka | PLETAL | cilostazol | TABLET;ORAL | 020863-001 | Jan 15, 1999 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Otsuka | PLETAL | cilostazol | TABLET;ORAL | 020863-002 | Jan 15, 1999 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PLETAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Otsuka | PLETAL | cilostazol | TABLET;ORAL | 020863-001 | Jan 15, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Otsuka | PLETAL | cilostazol | TABLET;ORAL | 020863-002 | Jan 15, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PLETAL
See the table below for patents covering PLETAL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Portugal | 70136 | ⤷ Sign Up | |
Italy | 1119929 | DERIVATI DEL TETRAZOLIL ALCOSSI CARBOSTIRILE E PROCEDIMENTO PER LA LORO FABBRICAZIONE | ⤷ Sign Up |
Netherlands | 183888 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |